Trials / Completed
CompletedNCT02034526
Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome.
A Randomised Controlled Trial of Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome and Dual Chamber Pacemaker.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 540 (actual)
- Sponsor
- Aarhus University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Atrial fibrillation (AF) is prevalent in patients with sick sinus syndrome (SSS) and associated with an increased risk of stroke and death. Within the first two years after pacemaker implantation almost half of the patients are diagnosed with AF. Studies have indicated that an increased amount of stimulation from the pacemaker in the atria is associated with an increased amount of AF. The aim of the present study is to test the hypothesis that a reduction of stimulation from the pacemaker in the atria, and reducing the minimal heart rate, increases the time to AF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DDDR-60 | DDDR, lower pacing rate 60 bpm, RR activated (low-moderate) |
| DEVICE | DDD-40 | DDD, lower pacing rate 40 bpm, RR function off |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2014-01-13
- Last updated
- 2024-02-08
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02034526. Inclusion in this directory is not an endorsement.